Pillar Pacific Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$728K Buy
3,897
+97
+3% +$19K 0.06% 159
2020
Q4
$642K Sell
3,800
-31
-0.8% -$4.63K 0.05% 181
2020
Q3
$567K Buy
3,831
+300
+8% +$46.4K 0.05% 178
2020
Q2
$580K Sell
3,531
-410
-10% -$62.9K 0.06% 167
2020
Q1
$547K Sell
3,941
-250
-6% -$34.4K 0.07% 157
2019
Q4
$551K Sell
4,191
-435
-9% -$50.4K 0.06% 171
2019
Q3
$517K Sell
4,626
-62
-1% -$6.9K 0.06% 171
2019
Q2
$519K Sell
4,688
-40
-0.8% -$4.71K 0.06% 177
2019
Q1
$614K Sell
4,728
-2,180
-32% -$265K 0.07% 159
2018
Q4
$799K Sell
6,908
-1,306
-16% -$146K 0.11% 142
2018
Q3
$881K Buy
8,214
+1,350
+20% +$135K 0.1% 141
2018
Q2
$586K Sell
6,864
-150
-2% -$12.3K 0.07% 169
2018
Q1
$543K Buy
7,014
+347
+5% +$27.9K 0.06% 169
2017
Q4
$563K Sell
6,667
-210
-3% -$17.9K 0.07% 168
2017
Q3
$588K Hold
6,877
0.08% 162
2017
Q2
$566K Sell
6,877
-200
-3% -$16.3K 0.08% 162
2017
Q1
$595K Buy
7,077
+20
+0.3% +$1.6K 0.08% 154
2016
Q4
$519K Sell
7,057
-69
-1% -$5.14K 0.08% 153
2016
Q3
$572K Hold
7,126
0.09% 143
2016
Q2
$561K Buy
7,126
+92
+1% +$6.93K 0.09% 141
2016
Q1
$507K Sell
7,034
-8,505
-55% -$644K 0.09% 149
2015
Q4
$1.31M Sell
15,539
-436
-3% -$36.2K 0.23% 110
2015
Q3
$1.34M Buy
15,975
+40
+0.3% +$3.38K 0.25% 115
2015
Q2
$1.33M Sell
15,935
-1,760
-10% -$134K 0.23% 114
2015
Q1
$1.29M Sell
17,695
-1,323
-7% -$94.2K 0.23% 110
2014
Q4
$1.31M Sell
19,018
-2,385
-11% -$161K 0.24% 109
2014
Q3
$1.39M Sell
21,403
-22,171
-51% -$1.4M 0.25% 108
2014
Q2
$2.71M Sell
43,574
-1,950
-4% -$116K 0.51% 88
2014
Q1
$2.68M Sell
45,524
-1,365
-3% -$76.2K 0.54% 82
2013
Q4
$2.39M Buy
46,889
+1,935
+4% +$96.9K 0.48% 89
2013
Q3
$2.26M Buy
44,954
+2,575
+6% +$135K 0.5% 87
2013
Q2
$2.08M Buy
+42,379
New +$2.31M 0.5% 88

Other funds holding LLY

Pillar Pacific Capital Management's LLY Position: Q1 2021 in Review

Pillar Pacific Capital Management increased its Eli Lilly (LLY) stake by 2.6% in Q1 2021, buying an estimated $19K and bringing the position to 3,897 shares worth $728K. The position accounts for 0.06% of the portfolio, ranked #159.

Pillar Pacific Capital Management first reported a position in LLY in Q2 2013 and has held it in 32 quarters since. The position peaked at $2.71M in Q2 2014. 1,948 funds tracked by Wall St. Rank hold LLY as of Q1 2021.

  • Pillar Pacific Capital Management held 3,897 shares of Eli Lilly worth $728K as of Q1 2021.
  • Pillar Pacific Capital Management bought 97 Eli Lilly shares in Q1 2021, an estimated $19K.
  • Eli Lilly made up 0.06% of Pillar Pacific Capital Management's portfolio in Q1 2021, its #159 holding.
  • Pillar Pacific Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 32 quarters since.
  • Pillar Pacific Capital Management's Eli Lilly position peaked at $2.71M in Q2 2014.
  • 1,948 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.

Based on Pillar Pacific Capital Management's 13F filing for Q1 2021, filed 4 May 2021.